Cannabis and Depression: Promising Animal Findings, Limited Evidence in People
Cannabis and depression: animal studies hint at CBD mood effects, but human evidence is limited; cannabis isn’t a proven treatment.
Articles
Cannabis Is Not an Established Treatment for ADHD: What the Evidence Shows
Discover why cannabis isn’t proven to treat ADHD, what current evidence really shows, and how to weigh risks and alternatives with a clinician.
Microdosing Cannabis: What Low-Dose Use Can (and Cannot) Promise
Microdosing cannabis: learn what a low-dose can promise, pick regulated products, assess risks, and know when to consult a clinician.
CBD Liver Findings in Mice Highlight Dose and Monitoring Concerns
A mouse study links high CBD doses to liver injury markers, highlighting dose, duration, and monitoring needs for CBD products in humans.
What Cannabis Inhalers Can (and Cannot) Do
Discover what cannabis inhalers can and cannot do—how dosing, safety, and device design affect relief, risks, and when to consult a clinician.
Cannabis-Based Medicines May Ease MS Spasticity, but They Are Not a Cure
Cannabis-based medicines may ease MS-related spasticity but aren't a cure, see what research shows, safety concerns, and when they complement standard MS care.
Marijuana Legalization Was Linked to Lower Adult Tobacco Use, but the Evidence Remains Mixed
Explore how marijuana legalization may influence adult tobacco use; early signals of decline, but evidence remains mixed for long-term effects and policy.
What Research Actually Shows About Cannabis and Sickle Cell Pain
What does research say about cannabis for sickle cell pain? A concise look at studies, limits, safety concerns and why larger trials are still needed.
How Extraction Method Changes the Chemistry of Cannabis Extracts
Discover how extraction methods reshape cannabis chemical profiles, revealing why full spectrum labels may mislead and why processing details matter.
Cannabis Study Links Two Weeks of Dispensary-Edible Use With Less Cancer Pain and Clearer Thinking
A real-world cannabis study from Colorado hints that two weeks of dispensary-use may ease cancer symptoms and sharpen thinking, but findings remain preliminary.